Methodological quality of RCTs evaluating ranibizumab for indirect comparison.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
AE: Adverse effects. *It was outstanding that in the 0.5 mg group 10.2% of patients discontinued because of adverse effects, in the 0.3 mg quarterly group 3.3% and in the 0.3 mg monthly group 4.3%, respectively.
创建时间：
2012-08-03
